Allen Webb - Global Medical President
| GMRE Stock | USD 8.86 0.06 0.68% |
President
Mr. Allen Webb is Executive Officer of the Company. He joined the Company in December 2014 and has served as Senior Vice President, SEC Reporting and Technical Accounting since October 2015. Mr. Webb was appointed by the Companys Board of Directors as an officer of the Company effective June 8, 2016. Mr. Webb has more than 25 years of experience in SEC reporting and technical accounting within multiple industries, including real estate, health care, oil and gas, government contracting, and public utilities. At Empire Mr. Webb served as Director of Financial Reporting from December 2012 to May 2013 and was promoted to Vice President and Corporationrationrate Controller from June 2013 to May 2014. Mr. Webb was an independent consultant during October and November of 2012 before joining Empire. Mr. Webb was the Director of SEC Reporting and Technical Accounting at Versar, Inc. from August 2011 to September 2012. From January 2011 to August 2011, Mr. Webb was an independent consultant. Prior to this, he served as the Director of Accounting at Coventry Health Care, Inc., which was acquired by Aetna in 2013. Mr. Webb joined Coventry in April 2008. Prior to joining Coventry, Mr. Webb was the Assistant Controller for Pepco Holdings, Inc., which merged with Exelon in 2016. Mr. Webb joined Pepco Holdings in August 1998. Prior to joining Pepco Holdings, Mr. Webb joined the real estate industry group within the SECs Division of Corporation Finance in March 1997 and joined Arthur Andersen in September 1990 where he served as the engagement manager on several REIT initial public offering engagements. Mr. Webb received his Bachelors of Science degree in Accounting from the University of Maryland with Summa Cum Laude honors. Mr. Webb is an active Certified Public Accountant in the state of Maryland. since 2016.
| Age | 50 |
| Tenure | 8 years |
| Address | 7373 Wisconsin Avenue, Bethesda, MD, United States, 20814 |
| Phone | 202 524 6851 |
| Web | https://www.globalmedicalreit.com |
Global Medical Management Efficiency
The company has return on total asset (ROA) of 0.0171 % which means that it generated a profit of $0.0171 on every $100 spent on assets. This is way below average. Global Medical's management efficiency ratios could be used to measure how well Global Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Global Medical's Return On Capital Employed is projected to slightly grow based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.02, whereas Return On Equity is forecasted to decline to 0.03. At present, Global Medical's Other Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 71 M, whereas Non Currrent Assets Other are forecasted to decline to about 644.7 M.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Michael Walsh | Boston Properties | 57 | |
| Yael Duffy | Office Properties Income | 44 | |
| Robert Bowers | Piedmont Office Realty | 64 | |
| Tyler Rose | Kilroy Realty Corp | 63 | |
| Peter Johnston | Boston Properties | 61 | |
| Jake Stroman | Boston Properties | N/A | |
| Ryan Hunt | Highwoods Properties | 47 | |
| Gregory Tylee | City Office | 52 | |
| Jeffrey Miller | Highwoods Properties | 53 | |
| Thomas Prescott | Piedmont Office Realty | 63 | |
| John Powers | Boston Properties | 73 | |
| Christopher Kollme | Piedmont Office Realty | 52 | |
| Michelle Ngo | Kilroy Realty Corp | 43 | |
| Robert Pester | Boston Properties | 63 | |
| Brendan Maiorana | Highwoods Properties | 48 | |
| Heidi Roth | Kilroy Realty Corp | 52 | |
| Frank Burt | Boston Properties | 61 | |
| Laura Moon | Piedmont Office Realty | 53 | |
| Eliott Trencher | Kilroy Realty Corp | 40 | |
| George Wells | Piedmont Office Realty | 61 | |
| Peter Otteni | Boston Properties | N/A | |
Management Performance
| Return On Equity | 0.0072 | ||||
| Return On Asset | 0.0171 |
Global Medical REIT Leadership Team
Elected by the shareholders, the Global Medical's board of directors comprises two types of representatives: Global Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Global. The board's role is to monitor Global Medical's management team and ensure that shareholders' interests are well served. Global Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Global Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Henry Cole, Lead Independent Director | ||
| Matthew Cypher, Independent Director | ||
| Robert CPA, CFO Treasurer | ||
| Robert Kiernan, Chief Financial Officer, Treasurer | ||
| Jingguo Zhang, Director | ||
| Huiqi Zhang, Director | ||
| Jamie Barber, General Counsel, Secretary | ||
| Roscoe Moore, Independent Director | ||
| Stephen Swett, Investor Executive | ||
| Ronald Marston, Independent Director | ||
| Jeffery Busch, President Chairman | ||
| Jeffrey JD, President Chairman | ||
| Lori Wittman, Independent Director | ||
| Paula Crowley, Independent Director | ||
| Danica Holley, Chief Operating Officer | ||
| Mary Jensen, Investor Professional | ||
| Alfonzo Leon, Chief Investment Officer | ||
| Allen Webb, Senior Vice President - SEC Reporting and Technical Accounting | ||
| Jeffrey Busch, Chairman of the Board , President , Chief Executive Officer |
Global Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Global Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0072 | ||||
| Return On Asset | 0.0171 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 1.29 B | ||||
| Shares Outstanding | 66.8 M | ||||
| Shares Owned By Insiders | 5.65 % | ||||
| Shares Owned By Institutions | 62.99 % | ||||
| Number Of Shares Shorted | 1.04 M | ||||
| Price To Earning | 39.78 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Global Medical REIT is a strong investment it is important to analyze Global Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global Medical's future performance. For an informed investment choice regarding Global Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Dividend Share 0.84 | Earnings Share (0.02) | Revenue Per Share 2.082 | Quarterly Revenue Growth (0.04) |
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.